Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $4.89M in the quarter ending September 30, 2024, with 47.94% growth. This brings the company's revenue in the last twelve months to $16.74M, up 81.08% year-over-year. In the year 2023, Stoke Therapeutics had annual revenue of $8.78M, down -29.22%.

• Revenue (ttm): $16.74M
• Revenue Growth: +81.08%
• P/S Ratio: 38.37
• Revenue / Employee: $152,209
• Employees: 110
• Market Cap: 667.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.